Chemical activators of KIAA1109 can modulate its activity through various signaling pathways by altering phosphorylation states. Forskolin functions by increasing intracellular cyclic AMP (cAMP) levels through the activation of adenylyl cyclase. The rise in cAMP subsequently activates protein kinase A (PKA), which can phosphorylate a range of proteins, including KIAA1109. Similarly, IBMX inhibits phosphodiesterases, thereby preventing cAMP degradation and enhancing PKA activity, which in turn can lead to the phosphorylation and activation of KIAA1109. Dibutyryl-cAMP, a cell-permeable analog of cAMP, bypasses cellular receptors and directly activates PKA. Once activated, PKA can target KIAA1109 among other proteins. Furthermore, Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), a family of enzymes that can phosphorylate serine and threonine residues on target proteins such as KIAA1109.
The activity of KIAA1109 can also be regulated by modulating calcium signaling and protein phosphatase inhibition. Ionomycin and A23187 (Calcimycin) are calcium ionophores that raise intracellular calcium levels, which can activate calcium-dependent protein kinases capable of phosphorylating KIAA1109. Thapsigargin promotes the release of stored calcium from the endoplasmic reticulum by inhibiting the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA), which in turn can activate calcium-dependent kinases that phosphorylate KIAA1109. On the other hand, Calyculin A and Okadaic Acid maintain proteins in a phosphorylated state by inhibiting protein phosphatases such as PP1 and PP2A. This mechanism can lead to an increased phosphorylation status and consequent activation of KIAA1109. Additionally, Epidermal Growth Factor (EGF) triggers receptor-mediated signaling cascades that activate downstream kinases, which may include those that phosphorylate KIAA1109. Lastly, Phosphatidic Acid activates mTOR signaling, which is known to phosphorylate a variety of downstream targets, potentially including KIAA1109, thereby influencing its activation state.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) inhibits phosphodiesterases, leading to an accumulation of cAMP by preventing its degradation. This increase in cAMP can enhance PKA activity, which may phosphorylate and activate KIAA1109. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which could phosphorylate target proteins including KIAA1109 as part of a signaling cascade. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is a potent inhibitor of protein phosphatases 1 and 2A, which prevents dephosphorylation of proteins, potentially leading to increased phosphorylation status and activation of proteins like KIAA1109. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid also inhibits protein phosphatases, particularly PP1 and PP2A, thereby maintaining proteins in a phosphorylated and active state. This could maintain or enhance the activation of KIAA1109. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that activates stress-activated protein kinases (SAPKs/JNKs), which could phosphorylate and activate KIAA1109 within their signaling pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as an ionophore for calcium, increasing intracellular calcium concentrations, which can activate calcium-dependent protein kinases that may target and activate KIAA1109. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to an increase in cytosolic calcium levels. This can activate calcium-dependent kinases that could phosphorylate and activate KIAA1109. | ||||||
Phosphatidic Acid, Dipalmitoyl | 169051-60-9 | sc-201057 sc-201057B sc-201057A | 100 mg 250 mg 500 mg | $106.00 $244.00 $417.00 | ||
Phosphatidic Acid acts as a signaling lipid that can activate mTOR signaling, potentially leading to the activation of downstream proteins including KIAA1109 through phosphorylation by mTOR or related kinases. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium, potentially activating calcium-dependent kinases which could phosphorylate and lead to the activation of KIAA1109. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that directly activates PKA, which could then phosphorylate and activate KIAA1109 as a downstream target within the signaling pathway. | ||||||